Amy Huang

979 total citations
20 papers, 683 citations indexed

About

Amy Huang is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Amy Huang has authored 20 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Infectious Diseases. Recurrent topics in Amy Huang's work include Pneumonia and Respiratory Infections (2 papers), COVID-19 Clinical Research Studies (2 papers) and Nosocomial Infections in ICU (2 papers). Amy Huang is often cited by papers focused on Pneumonia and Respiratory Infections (2 papers), COVID-19 Clinical Research Studies (2 papers) and Nosocomial Infections in ICU (2 papers). Amy Huang collaborates with scholars based in United States, Taiwan and China. Amy Huang's co-authors include Annie A. Wu, Virginia E. Drake, Lei Zheng, Chien‐Chang Lee, Richard L. Robertson, Chiao‐Ling Tsai, Shuei‐Liong Lin, Janice Chang, J. Chen and Wan‐Ting Hsu and has published in prestigious journals such as Scientific Reports, Radiology and Free Radical Biology and Medicine.

In The Last Decade

Amy Huang

19 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Huang United States 11 179 155 146 127 123 20 683
Ashish Sharma United States 14 214 1.2× 212 1.4× 338 2.3× 172 1.4× 136 1.1× 33 775
Patricia Castillo United States 12 94 0.5× 137 0.9× 91 0.6× 128 1.0× 80 0.7× 31 613
Takayuki Hoshina Japan 13 166 0.9× 96 0.6× 131 0.9× 62 0.5× 83 0.7× 82 583
E. Scott Halstead United States 15 249 1.4× 137 0.9× 439 3.0× 67 0.5× 130 1.1× 46 845
S. Radhakrishnan India 13 205 1.1× 123 0.8× 50 0.3× 95 0.7× 58 0.5× 64 647
Thomas Böhler Germany 14 102 0.6× 86 0.6× 212 1.5× 75 0.6× 180 1.5× 49 629
Marcello Mariani Italy 15 87 0.5× 101 0.7× 84 0.6× 27 0.2× 117 1.0× 57 713
Michael J. Blend United States 15 116 0.6× 208 1.3× 71 0.5× 104 0.8× 79 0.6× 70 782
Paul Schneider Germany 19 301 1.7× 311 2.0× 166 1.1× 81 0.6× 153 1.2× 47 975
Juan R. Velázquez Mexico 15 141 0.8× 112 0.7× 270 1.8× 76 0.6× 96 0.8× 37 821

Countries citing papers authored by Amy Huang

Since Specialization
Citations

This map shows the geographic impact of Amy Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Huang more than expected).

Fields of papers citing papers by Amy Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Huang. The network helps show where Amy Huang may publish in the future.

Co-authorship network of co-authors of Amy Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Huang. A scholar is included among the top collaborators of Amy Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Huang. Amy Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Shu‐Man, Yu‐Chang Liu, Jyh‐Ping Hsu, et al.. (2025). Association of SGLT2 inhibitors and GLP-1 receptor agonists with the risk of Parkinson’s disease in patients with type 2 diabetes: A propensity score–matched cohort study with meta-analysis. Diabetes Research and Clinical Practice. 229. 112914–112914. 1 indexed citations
2.
Liu, Yu‐Chang, Amy Huang, Carol Chiung‐Hui Peng, et al.. (2025). SGLT2 inhibitors and nephrolithiasis risk in patients with type 2 diabetes: A cohort study and meta-analysis. Diabetes Research and Clinical Practice. 222. 112088–112088. 1 indexed citations
3.
Huang, Amy, et al.. (2024). Predicting mortality in hospitalized influenza patients: integration of deep learning-based chest X-ray severity score (FluDeep-XR) and clinical variables. Journal of the American Medical Informatics Association. 33(1). 133–143.
4.
Huang, Amy, Xu Gao, Yuxin Guo, et al.. (2024). Trends in diabetic ketoacidosis‐ and hyperosmolar hyperglycemic state‐related mortality during theCOVID‐19 pandemic in the United States: A population‐based study. Journal of Diabetes. 16(8). e13591–e13591. 1 indexed citations
5.
Gao, Xu, Amy Huang, Jian Zu, et al.. (2022). Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States. EClinicalMedicine. 54. 101671–101671. 28 indexed citations
6.
Dou, Qingli, Jiangping Liu, Wenwu Zhang, et al.. (2022). Dynamic changes in heparin-binding protein as a prognostic biomarker for 30-day mortality in sepsis patients in the intensive care unit. Scientific Reports. 12(1). 10751–10751. 13 indexed citations
7.
Lee, Chien‐Chang, Meng-tse Gabriel Lee, I‐Hsuan Huang, et al.. (2022). Genome-wide association study of primary dysmenorrhea in the Taiwan Biobank validates associations near the NGF and IL1 gene loci. Journal of Human Genetics. 67(8). 449–458. 1 indexed citations
8.
Hu, Jiun‐Ruey, Chia‐Hung Yo, Hsin-Ying Lee, et al.. (2022). Risk-standardized sepsis mortality map of the United States. Digital Health. 8. 2282029828–2282029828. 8 indexed citations
9.
Koh, Christopher, Julian Hercun, Amy Huang, et al.. (2020). A Phase 2 Study of Peginterferon Lambda, Lonafarnib and Ritonavir for 24 Weeks: End-of-Treatment Results from the LIFT HDV Study. Journal of Hepatology. 73. S130–S130. 31 indexed citations
10.
Huang, Amy, Ye Liu, Tzu-Chun Hsu, et al.. (2019). Survival Impact and Clinical Predictors of Acute Gastrointestinal Bleeding in Patients With Bloodstream Infection. Journal of Intensive Care Medicine. 36(1). 63–69. 8 indexed citations
11.
Hsieh, Ronan W., Tzu‐Chun Hsu, Matthew Lee, et al.. (2019). Comparison of type B dissection by open, endovascular, and medical treatments. Journal of Vascular Surgery. 70(6). 1792–1800.e3. 20 indexed citations
12.
Smith, Mariana Magnus, et al.. (2017). Clinical presentation and airway management of tracheal atresia: A systematic review. International Journal of Pediatric Otorhinolaryngology. 101. 57–64. 17 indexed citations
13.
Huang, Amy, et al.. (2017). Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis. Clinical Microbiology and Infection. 24(10). 1055–1063. 178 indexed citations
14.
Podszun, Maren C., Hongyi Cai, Ahmad S. Alawad, et al.. (2017). Vitamin E (RRR-α-tocopherol) decreases hepatic de novo lipogenesis. Free Radical Biology and Medicine. 112. 30–31. 1 indexed citations
15.
Huang, Amy, Sean Tackett, & Ming‐Jung Ho. (2015). Learning Environment Assessment of Clinical Students at National Taiwan University. 19(2). 65–78. 1 indexed citations
16.
Wu, Annie A., et al.. (2015). Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells. OncoImmunology. 4(7). e1016700–e1016700. 217 indexed citations
17.
Huang, Amy, et al.. (2006). Vitamin E attenuates crystal formation in rat kidneys: Roles of renal tubular cell death and crystallization inhibitors. Kidney International. 70(4). 699–710. 70 indexed citations
18.
Huang, Amy. (2005). The Hot Nose Sign. Radiology. 235(1). 216–217. 14 indexed citations
19.
Huang, Amy & Richard L. Robertson. (2004). Spontaneous superficial parenchymal and leptomeningeal hemorrhage in term neonates.. American Journal of Neuroradiology. 25(3). 469–75. 63 indexed citations
20.
Huang, Amy, et al.. (1980). An Evaluation of Antithrombin III Laboratory Tests. American Journal of Clinical Pathology. 73(4). 537–540. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashish Sharma Breakdown of academic impact, for papers by Patricia Castillo Breakdown of academic impact, for papers by Takayuki Hoshina Breakdown of academic impact, for papers by E. Scott Halstead Breakdown of academic impact, for papers by S. Radhakrishnan Breakdown of academic impact, for papers by Thomas Böhler Breakdown of academic impact, for papers by Marcello Mariani Breakdown of academic impact, for papers by Michael J. Blend Breakdown of academic impact, for papers by Paul Schneider Breakdown of academic impact, for papers by Juan R. Velázquez
Rankless by CCL
2026